|
|
|
|
|
1
|
Prostate Cancer Drug Discoveries: What the Future Holds |
Nov 2009 |
$2,460.00 |
|
Prostate cancer is the second leading cause of cancer in the US and the third most common cancer worldwide. More than two million men in the US suffer with prostate cancer. Find out more about
more...
Published by: Espicom Healthcare Intelligence
| Search inside this report |

|
|
2
|
Competitor Analysis: TGF-R Agonists and Antagonists |
Nov 2009 |
$297.00 |
|
The present Competitive Intelligence Report about TGF-R agonists and antagonists provides a competitor evaluation in the field of transforming growth factor receptor (TGF-R) or TGF targeting molecules for tissue healing or treatment of cancer and
more...
Published by: La Merie S.L.
|

|
|
3
|
Protein Kinase Therapeutics in Oncology - Where to Commercialize? |
Oct 2009 |
$3,500.00 |
|
This report comprises defined and up to date development strategies for 409 protein kinase drugs (990 projects) within the portfolio of 160 investigators, from Ceased to Marketed. The report extensively analyses 133 identified targets of
more...
Published by: BioSeeker Group AB
|

|
|
4
|
CDK Inhibitors Patent Landscape 2009 |
Oct 2009 |
$1,645.00 |
|
IP Overview presents a patent landscape analysis of the CDK Inhibitor field.
Alterations in CDK activity have been associated in the development of viral infections, neurodegenerative dis orders such as Alzheimer’s disease and proliferative
more...
Published by: France Innovation Scientifique et Transfer
| Search inside this report |

|
|
5
|
Pipeline Insight: Colorectal Cancer - Growing trend towards personalized medicine |
Oct 2009 |
$11,400.00 |
|
Introduction CRC incidence will be over 490,000 cases by 2018 in the seven major markets. This large patient base will translate into a high commercial potential for the development of novel, more effective therapies. Currently, there
more...
Published by: Datamonitor
|

|
|
6
|
Stakeholder Insight: Acute Leukemias - Reaching the limits of cytotoxic chemotherapy |
Oct 2009 |
$15,200.00 |
|
Introduction The drug therapy of acute myeloid leukemia (AML) and adult acute lymphoblastic leukemia (ALL) is largely based on chemotherapy regimens that have changed little in the past few decades. Patient outcomes for both diseases remain
more...
Published by: Datamonitor
|

|
|
7
|
Top 20 Cancer Therapy Brands Forecast |
Oct 2009 |
$15,200.00 |
|
Introduction The cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer therapy sales totaled over $38 billion in the seven major
more...
Published by: Datamonitor
|

|
|
8
|
Forecast Insight: Top 20 Cancer Therapy Brands Targeted therapies will drive market growth in the wake of the cytotoxic and antihormonal patent cliff |
Sep 2009 |
$15,200.00 |
|
Introduction
The cancer therapies market offers a high level of commercial reward to a handful of companies including Roche, Sanofi-Aventis, AstraZeneca, Novartis and Eli Lilly. Cancer therapy sales totaled over $38 billion in the seven
more...
Published by: Datamonitor
|

|
|
9
|
Strategic Analysis of the Bladder Cancer Therapeutics |
Sep 2009 |
$1,500.00 |
|
In this report, Intellent focuses on the unmet medical need of the global bladder cancer market. Our new primary research driven report focuses on the currently available therapeutics to deal with this disease. Our unique
more...
Published by: Intellent
| Search inside this report |

|
|
10
|
Cancer Pancreatic Cancer Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Pancreatic Cancer Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of pancreatic cancer drugs by company and by stage as
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
11
|
Cancer Prostate Cancer Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Prostate Cancer Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of prostate cancer drugs by company and by stage as
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
12
|
Cancer Ovarian Cancer Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Ovarian Cancer Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of ovarian cancer drugs by company and by stage as
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
13
|
Cancer Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Non-Small-Cell Lung Cancer or Lung Cancer or Small Cell Lung Cancer Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
14
|
Cancer Non-Hodgkin Lymphoma Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Non-Hodgkin Lymphoma Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of non-hodgkin lymphoma drugs by company and by stage as
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
15
|
Cancer Multiple Myeloma Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Multiple Myeloma Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of multiple myeloma drugs by company and by stage as
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
16
|
Cancer Melanoma or Skin Cancer Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Melanoma or Skin Cancer Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of melanoma or skin cancer drugs by company
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
17
|
Cancer Lymphoma Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Lymphoma Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of lymphoma drugs by company and by stage as well as
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
18
|
Cancer Liver Cancer Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Liver Cancer Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of liver cancer drugs by company and by stage as
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
19
|
Cancer Kidney Cancer Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Kidney Cancer Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of kidney cancer drugs by company and by stage as
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
20
|
Cancer Head and Neck Cancer Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Head and Neck Cancer Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of head and neck cancer drugs by company
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
21
|
Cancer Gastrointestinal (Stomach) Cancer Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Gastrointestinal (Stomach) Cancer Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of gastrointestinal (stomach) cancer drugs by company and by
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
22
|
Cancer Colorectal Cancer or Colon Cancer Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Colorectal Cancer or Colon Cancer Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of colorectal cancer or colon cancer drugs
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
23
|
Cancer Breast Cancer Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Breast Cancer Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of breast cancer drugs by company and by stage as
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
24
|
Cancer Brain Tumor Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Brain Tumor Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of brain tumor drugs by company and by stage as
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
25
|
Cancer Bladder Cancer Therapy Area Pipeline Report |
Sep 2009 |
$1,495.00 |
|
Life Science Analytics', Bladder Cancer Therapy Area Pipeline Report contains detailed information on the allergy drug pipeline. This report provides insight into the pipeline status of bladder cancer drugs by company and by stage as
more...
Published by: Life Science Analytics (LSA)
| Search inside this report |

|
|
|
|
|